Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

NCT03893370 is registered in ClinicalTrials.gov with CSA Medical, Inc. as lead sponsor.

NCT NCT03893370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03893370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
Lead sponsor
CSA Medical, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 9, 2020
Completion date
September 30, 2026
Enrollment
210 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis